Proventil HFA: Difference between revisions
mNo edit summary |
m (Protected "Proventil HFA": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 5: | Line 5: | ||
==Dosing and Administration== | ==Dosing and Administration== | ||
'''General treatment'''<br> | '''General treatment'''<br> | ||
For treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms, the usual dosage for adults and children 4 years of age and older is two inhalations repeated every 4 to 6 hours. More frequent administration or a larger number of inhalations is not recommended. In some patients, one inhalation every 4 hours may be sufficient. Each actuation of Proventil HFA Inhalation Aerosol delivers 108 mcg of albuterol sulfate (equivalent to 90 mcg of albuterol base) from the mouthpiece. It is recommended to prime the inhaler before using for the first time and in cases where the inhaler has not been used for more than 2 weeks by releasing four | For treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms, the usual dosage for adults and children 4 years of age and older is two inhalations repeated every 4 to 6 hours. More frequent administration or a larger number of inhalations is not recommended. In some patients, one inhalation every 4 hours may be sufficient. Each actuation of Proventil HFA Inhalation Aerosol delivers 108 mcg of albuterol sulfate (equivalent to 90 mcg of albuterol base) from the mouthpiece. It is recommended to prime the inhaler before using for the first time and in cases where the inhaler has not been used for more than 2 weeks by releasing four “test sprays” into the air, away from the face. | ||
<br> | <br> | ||
<br> | <br> | ||
''For more information on dosing please refer to'' [ | ''For more information on dosing please refer to'' [[Proventil HFA instructions for administration|Instructions for administration]] | ||
<br> | <br> | ||
---- | ---- | ||
<br> | <br> | ||
<font size="4"> | <font size="4"> | ||
[ | [[{{PAGENAME}}#FDA Package Insert Resources|FDA Package Insert Resources]] | ||
<br></font size><small>Indications, Contraindications, Side Effects, Drug Interactions, etc.</small><font size="4"><br> | <br></font size><small>Indications, Contraindications, Side Effects, Drug Interactions, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[http:// | [http://www.pace-med-apps.com/gfrcalc.htm Calculate Creatine Clearance] | ||
<br></font size><small>On line calculator of your patients Cr Cl by a variety of formulas.</small><font size="4"><br> | <br></font size><small>On line calculator of your patients Cr Cl by a variety of formulas.</small><font size="4"><br> | ||
<br> | <br> | ||
[http:// | [http://home.earthlink.net/~sensei11/convert.htm Convert pounds to Kilograms] | ||
<br></font size><small>On line calculator of your patients weight in pounds to Kg for dosing estimates.</small><font size="4"><br> | <br></font size><small>On line calculator of your patients weight in pounds to Kg for dosing estimates.</small><font size="4"><br> | ||
<br> [ | <br> [[{{PAGENAME}}#Publication Resources|Publication Resources]] | ||
<br></font size><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br> | <br></font size><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Trial Resources|Trial Resources]] | ||
<br></font size><small>Ongoing Trials, Trial Results</small><font size="4"><br> | <br></font size><small>Ongoing Trials, Trial Results</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Guidelines & Evidence Based Medicine Resources|Guidelines & Evidence Based Medicine Resources]] | ||
<br></font size><small>US National Guidelines, Cochrane Collaboration, etc.</small><font size="4"><br> | <br></font size><small>US National Guidelines, Cochrane Collaboration, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#Media Resources|Media Resources]] | ||
<br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br> | <br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br> | ||
[ | [[{{PAGENAME}}#Patient Resources|Patient Resources]] | ||
<br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br> | <br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}}#International Resources|International Resources]] | ||
<br></font size><small>en | <br></font size><small>en Español</small><font size="4"><br> | ||
<br> | <br> | ||
---- | ---- | ||
Line 45: | Line 45: | ||
==FDA Package Insert Resources== | ==FDA Package Insert Resources== | ||
[ | [[{{PAGENAME}} indications|Indications]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} contraindications|Contraindications]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} side effects|Side Effects]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} drug interactions|Drug Interactions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} precautions|Precautions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} overdose|Overdose]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} instructions for administration|Instructions for Administration]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} how supplied|How Supplied]] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.fda.gov/cder/foi/label/1998/20503s4lbl.pdf FDA label] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://google2.fda.gov/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&x=0&y=0&client=FDA&site=FDA&lr=&proxystylesheet=FDA&output=xml_no_dtd&getfields=* FDA on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Publication Resources== | ==Publication Resources== | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most Recent Articles on {{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}%20AND%20systematic%5Bsb%5D Review Articles on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28%28N+Engl+J+Med%5Bta%5D%29+OR+%28Lancet%5Bta%5D%29+OR+%28BMJ%5Bta%5D%29%29 Articles on {{PAGENAME}} in N Eng J Med, Lancet, BMJ] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://books.google.com/books?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=gp Textbook Information on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Trial Resources== | ==Trial Resources== | ||
[http:// | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials with {{PAGENAME}} at Clinical Trials.gov] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28randomized+controlled+trial%5BPublication+Type%5D+OR+%28randomized%5BTitle%2FAbstract%5D+AND+controlled%5BTitle%2FAbstract%5D+AND+trial%5BTitle%2FAbstract%5D%29%29 Trial Results with {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Guidelines & Evidence Based Medicine Resources== | ==Guidelines & Evidence Based Medicine Resources== | ||
[http:// | [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cochrane Database Syst Rev[ta])}} Cochrane Collaboration on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cost effectiveness)}} Cost Effectiveness of {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Media Resources== | ==Media Resources== | ||
[http:// | [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint Slides on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://images.google.com/images?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wi Images of {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla%3Aen-US%3Aofficial&hs=hPo&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+podcasts+OR+MP3&btnG=Search Podcasts & MP3s on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://video.google.com/videosearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&um=1&sa=N&tab=fv# Videos on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Patient Resources== | ==Patient Resources== | ||
[ | [[{{PAGENAME}} (patient information)|Patient Information from National Library of Medicine]] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:for_patients&cx=disease_for_patients&sa=N&oi=cooptsr&resnum=0&ct=col3&cd=1 Patient Resources on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://groups.google.com/groups/search?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search Discussion Groups on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.google.com/search?hl=en&client=firefox-a&rls=org.mozilla:en-US:official&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+more:patient_handouts&cx=disease_for_health_professionals&sa=N&oi=coopctx&resnum=0&ct=col1&cd=3 Patient Handouts on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://news.google.com/news?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wn {{PAGENAME}} in the News] | ||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://finance.google.com/finance?ie=UTF-8&oe=utf-8&q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&qt_s=Search&sa=N&tab=te {{PAGENAME}} in the Marketplace] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==International Resources== | ==International Resources== | ||
[http:// | [http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+en+espanol&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a {{PAGENAME}} en Español] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> |
Latest revision as of 18:19, 27 September 2011
Synonyms / Brand Names:
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
General treatment
For treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms, the usual dosage for adults and children 4 years of age and older is two inhalations repeated every 4 to 6 hours. More frequent administration or a larger number of inhalations is not recommended. In some patients, one inhalation every 4 hours may be sufficient. Each actuation of Proventil HFA Inhalation Aerosol delivers 108 mcg of albuterol sulfate (equivalent to 90 mcg of albuterol base) from the mouthpiece. It is recommended to prime the inhaler before using for the first time and in cases where the inhaler has not been used for more than 2 weeks by releasing four “test sprays” into the air, away from the face.
For more information on dosing please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
FDA label
FDA on Proventil HFA
Return to top
Publication Resources
Most Recent Articles on Proventil HFA
Review Articles on Proventil HFA
Articles on Proventil HFA in N Eng J Med, Lancet, BMJ
Textbook Information on Proventil HFA
Return to top
Trial Resources
Ongoing Trials with Proventil HFA at Clinical Trials.gov
Trial Results with Proventil HFA
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Proventil HFA
Cochrane Collaboration on Proventil HFA
Cost Effectiveness of Proventil HFA
Return to top
Media Resources
Powerpoint Slides on Proventil HFA
Images of Proventil HFA
Podcasts & MP3s on Proventil HFA
Videos on Proventil HFA
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Proventil HFA
Discussion Groups on Proventil HFA
Patient Handouts on Proventil HFA
Blogs on Proventil HFA
Proventil HFA in the News
Proventil HFA in the Marketplace
Return to top
International Resources
Proventil HFA en Español
Return to top
Adapted from the FDA Package Insert.